Literature DB >> 340918

Transposition and insertion of intact, deleted and enlarged ampicillin transposon Tn3 from mini-R1 (Rsc) plasmids into transfer factors.

W Goebel, W Lindenmaier, F Pfeifer, H Schrempf, B Schelle.   

Abstract

The miniR1-(Rsc)-plasmids which derive from the copy mutant R1drd-19B2 (pKN102) are non-conjugative extrachromosomal elements which can not be co-transferred by various transfer factors to recipient strains under standard mating conditions. The attempts to mobilize Rsc11 by F'lac lead to transconjugants carrying F'lac::Tn3 with Tn3 mainly inserted into the lac operon. In addition it can be shown that Rsc11 can become inserted as a complete unit into the transfer factor giving rise to rather unstable recombinant intermediates. Dissociation of these intermediates may lead to alterations of the original plasmids. The Tn3 part of Rsc13 can be enlarged or deleted by in vitro manipulations. In vitro insertion of EcoRI-fragments into an EcoRI+ site of Tn3 leads to new transposable units which can be transposed to the RTF part of R1. This new genetic entity can be stably integrated into the chromosome of E. coli by integrative suppression of a dnaAts-mutation. Deletions at one end or the central region of Tn3 abolish the capability of transposition. However, the Rsc-plasmids containing the deleted Tn3 can still be inserted into the transfer factor as complete units. The resulting recombinants are unstable leading after dissociation in some cases to new plasmids with altered properties.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 340918     DOI: 10.1007/bf00267389

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  21 in total

1.  Mutagenesis by insertion of a drug-resistance element carrying an inverted repetition.

Authors:  N Kleckner; R K Chan; B K Tye; D Botstein
Journal:  J Mol Biol       Date:  1975-10-05       Impact factor: 5.469

2.  Class of small multicopy plasmids originating from the mutant antibiotic resistance factor R1 drd-19B2.

Authors:  W Goebel; R Bonewald
Journal:  J Bacteriol       Date:  1975-08       Impact factor: 3.490

3.  Characterization of small ampicillin resistance plasmids (Rsc) originating from the mutant antibiotic resistance factor R1drd-19B2.

Authors:  G Luibrand; D Blohm; H Mayer; W Goebel
Journal:  Mol Gen Genet       Date:  1977-03-28

4.  Transposition of ampicillin resistance from RP4 to other replicons.

Authors:  R W Hedges; A E Jacob
Journal:  Mol Gen Genet       Date:  1974

5.  Construction of biologically functional bacterial plasmids in vitro.

Authors:  S N Cohen; A C Chang; H W Boyer; R B Helling
Journal:  Proc Natl Acad Sci U S A       Date:  1973-11       Impact factor: 11.205

6.  Integrative suppression of temperature-sensitive mutants iwth a lesion in the initiation of DNA replication. Replication of autonomous plasmids in the suppressed state.

Authors:  W Goebel
Journal:  Eur J Biochem       Date:  1974-03-15

7.  Chromosome replication in Escherichia coli. IV. Control of chromosome replication and cell division by an integrated episome.

Authors:  Y Nishimura; L Caro; C M Berg; Y Hirota
Journal:  J Mol Biol       Date:  1971-02-14       Impact factor: 5.469

8.  Translocation of a plasmid DNA sequence which mediates ampicillin resistance: molecular nature and specificity of insertion.

Authors:  F Heffron; C Rubens; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

Review 9.  Transposable genetic elements and plasmid evolution.

Authors:  S N Cohen
Journal:  Nature       Date:  1976-10-28       Impact factor: 49.962

10.  Transposition of R factor genes to bacteriophage lambda.

Authors:  D E Berg; J Davies; B Allet; J D Rochaix
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

View more
  14 in total

1.  Transformation-derived Neisseria gonorrhoeae plasmids with altered structure and function.

Authors:  T E Sox; W Mohammed; P F Sparling
Journal:  J Bacteriol       Date:  1979-05       Impact factor: 3.490

2.  Cloning of the entire region for nitrogen fixation from Klebsiella pneumoniae on a multicopy plasmid vehicle in Escherichia coli.

Authors:  A Pühler; H J Burkardt; W Klipp
Journal:  Mol Gen Genet       Date:  1979-10-02

3.  Transposon-mediated conjugational transmission of nonconjugative plasmids.

Authors:  N J Crisona; J A Nowak; H Nagaishi; A J Clark
Journal:  J Bacteriol       Date:  1980-05       Impact factor: 3.490

4.  In vitro mutagenesis of a circular DNA molecule by using synthetic restriction sites.

Authors:  F Heffron; M So; B J McCarthy
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

5.  Isolation and characterization of the minimal fragment required for autonomous replication ("basic replicon") of a copy mutant (pKN102) of the antibiotic resistance factor R1.

Authors:  R Kollek; W Oertel; W Goebel
Journal:  Mol Gen Genet       Date:  1978-06-01

6.  Dissection of the transposition process: a transposon-encoded site-specific recombination system.

Authors:  A Arthur; D Sherratt
Journal:  Mol Gen Genet       Date:  1979-10-01

7.  High incidence of transposon Tn3 insertions into a replication control gene of the chimeric R/Ent plasmid pCG86 of Escherichia coli.

Authors:  R N Picken; A J Mazaitis; W K Maas
Journal:  J Bacteriol       Date:  1984-10       Impact factor: 3.490

8.  The expression of tetracycline resistance after insertion of foreign DNA fragments between the EcoRI and HindIII sites of the plasmid cloning vector pBR 322.

Authors:  G Widera; F Gautier; W Lindenmaier; J Collins
Journal:  Mol Gen Genet       Date:  1978-07-25

9.  Mapping of Streptococcus faecalis plasmids pAD1 and pAD2 and studies relating to transposition of Tn917.

Authors:  D B Clewell; P K Tomich; M C Gawron-Burke; A E Franke; Y Yagi; F Y An
Journal:  J Bacteriol       Date:  1982-12       Impact factor: 3.490

10.  Tn2301, a transposon construct carrying the entire transfer region of the F plasmid.

Authors:  D A Johnson; N S Willetts
Journal:  J Bacteriol       Date:  1980-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.